Biotech Values

[jbog]

Abbvie's HCV results reported this morning shows another 12% Q to Q drop and now sits at $698 mil.

I guess all the data projections were nothing but pipe dreams from day one.

These results will put another fork in Enta.

AbbVie reports Q3 Global HCV net revenues $698M Global HCV net revenues were $698M, a decrease of 19% on a reported basis, or 18.6% operationally. In the U.S., HCV net revenues of $368M decreased 17% in the quarter. Internationally, HCV net revenues of $330M decreased 21.2% on a reported basis, or 20.4% operationally.

Read more at:
https://thefly.com/landingPageNews.php?id=2985941